Susquehanna International Group
SURF

Susquehanna International Group’s Surface Oncology, Inc. Common Stock SURF Stock Holding History

Susquehanna International Group’s Portfolio SURF Stock Details SURF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-54,400
Closed -$89K – 14464
2022
Q2 		$89K Buy
54,400
+43,300
+390% +$89.9K ﹤0.01% 11580
2022
Q1 		$33K Sell
11,100
-11,100
-50% -$38.9K ﹤0.01% 12479
2021
Q4 		$106K Sell
22,200
-85,300
-79% -$550K ﹤0.01% 12110
2021
Q3 		$814K Sell
107,500
-100,400
-48% -$642K ﹤0.01% 8087
2021
Q2 		$1.55M Buy
207,900
+80,000
+63% +$617K ﹤0.01% 6547
2021
Q1 		$998K Buy
127,900
+48,800
+62% +$488K ﹤0.01% 7747
2020
Q4 		$731K Buy
+79,100
New +$688K ﹤0.01% 7429

Susquehanna International Group's SURF Position: Q3 2023 in Review

Susquehanna International Group sold out of Surface Oncology, Inc. Common Stock (SURF) in Q3 2023, closing a stake of 52,149 shares — an estimated $45.3K sold.

Susquehanna International Group first reported a position in SURF in Q4 2020 and held it in 11 quarters. The position peaked at $3.19M in Q1 2021. 0 funds tracked by Wall St. Rank hold SURF as of Q3 2023.

  • Susquehanna International Group reported no remaining Surface Oncology, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Susquehanna International Group sold 52,149 Surface Oncology, Inc. Common Stock shares in Q3 2023, an estimated $45.3K.
  • Susquehanna International Group first reported a position in Surface Oncology, Inc. Common Stock in Q4 2020 and held it in 11 quarters.
  • Susquehanna International Group's Surface Oncology, Inc. Common Stock position peaked at $3.19M in Q1 2021.
  • 0 funds tracked by Wall St. Rank held Surface Oncology, Inc. Common Stock as of Q3 2023.

Based on Susquehanna International Group's 13F filing for Q3 2023, filed 14 Nov 2023.